Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-services domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-payments domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121
AMACR – benchmark antibodies AMACR
Skip to content
Close

Showing all 5 results

AMACR

AMACR (Alpha-Methylacyl-CoA Racemase): AMACR is an important marker in prostate pathology, particularly for distinguishing between benign prostatic hyperplasia and prostate cancer. Elevated AMACR expression is associated with malignant transformation, making it a valuable diagnostic tool when assessing prostatic tissues, especially in needle biopsy specimens.



target type reactivity applications
No products found

Human prostate carcinoma stained anti-AMACR antibody using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands.
IHC with antibody [6017] : Human prostate carcinoma stained anti-AMACR antibody using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands.
Human prostate carcinoma stained anti-AMACR and anti-p63 antibodies using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands with AMACR and basal cell nuclear staining with p63.
IHC with antibody [6018] : Human prostate carcinoma stained anti-AMACR and anti-p63 antibodies using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands with AMACR and basal cell nuclear staining with p63.
Human prostate carcinoma stained anti-AMACR and anti-p63 antibodies using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands with AMACR and basal cell nuclear staining with p63.
IHC with antibody [6019] : Human prostate carcinoma stained anti-AMACR and anti-p63 antibodies using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands with AMACR and basal cell nuclear staining with p63.
ICC
IHC